Nephrology and Urology

41 Items

All Items

Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study

Nargiz Majidova, Mustafa Seyyar, Demet Işık Bayraktar, Gülhan Dinç, Elfag İsgandarov, Javid Huseynov, Alper Yaşar, Abdussamet Çelebi, Nadiye Sever, Erkam Kocaaslan, Pınar Erel, Yeşim Ağyol, Ali Kaan Güren, Rukiye Arıkan, Selver Işık, Özlem Ercelep, Güzin Demirağ, Umut Kefeli, Osman Köstek, İbrahim Vedat Bayoğlu, Murat Sarı

1776–1784
Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity

Yanyuan Wu, Yedie He, Jun Qi, Song Wang, Zongping Wang

170–175
Tribbles pseudokinase 3 promoted renal fibrosis by regulating the expression of DNA damage-inducible transcript 3 in diabetic nephropathy

Lulu Kong, Liusha Kong, Peipei Li, Li Gao, Hongqin Ma, Bimin Shi

1559–1570
Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy

Chao Zhang, Yanlang Yang

688–697
Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration

Xuefei Wang, Fangqi Deng, Jiexi Liu, Jiayu Wang, Qing Chen, Jiabin Lu

912-922
Serum cytokine profiles in children with IgA vasculitis with nephritis

Yanyan Jin, Xue He, Weiqiang Lin, Zhaoyang Peng, Wei Li, Wenqing Xiang, Zhihui Chen, Haidong Fu, Jianhua Mao

1425–1443
Risk of graft loss in kidney transplant recipients after aortic valve replacement

Stefan Büttner, Carolin Zöller, Sammy Patyna, Anisa Gradascevic, Helge Weiler, Mark Rosenberg, Thomas Walther, Andreas M. Zeiher, Helmut Geiger, Mariuca Vasa-Nicotera, Ingeborg Hauser, Stephan Fichtlscherer

145-152
Risk factors for recurrent IgA nephropathy after renal transplantation: A meta-analysis

Jiang Bai, Qiong Wu, Jing Chen, Zhifang Zheng, Jiarong Chang, Liangliang Wang, Yun Zhou, Qiang Guo

364–375
Prognostic impact of sleep-disordered breathing on mortality and cardiovascular events in renal dialysis: A meta-analysis

Tingting Hao, Yingjiao Shen, Xiaofeng Lu
Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Marija Kraljević, Inga Marijanović, Maja Barbarić, Emir Sokolović, Merima Bukva, Timur Cerić, Teo Buhovac

161-169
Predicting overactive bladder from inflammatory markers: A machine learning approach using NHANES 2005–2020

Haoxun Zhang, Guoling Zhang, Chunyang Wang

2229–2242
PD-L1 expression in testicular germ cell tumors undergoing spontaneous regression

Ivan Novak, Miroslav Tomić, Denis Mulabdić, Ivan Pezelj, Slaven Čiček, Igor Tomašković, Nino Sinčić, Božo Krušlin, Monika Ulamec

1751–1760
Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

Zhenchi Li, Zhibin Xu, Jiangping Wang, Mei Wang

633–646
Naringenin – a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence

Estefania Valle-Velázquez, Oscar René Zambrano-Vásquez, Fernando Cortés-Camacho, Laura Gabriela Sánchez-Lozada, Gustavo Guevara-Balcázar, Horacio Osorio-Alonso

1441–1451
Molecular basis and therapeutic targets in prostate cancer: A comprehensive review

Florentina Claudia Militaru, Valentin Militaru, Nicolae Crisan, Ioana Corina Bocsan, Anghel Adrian Udrea, Andreea Catana, Eniko Kutasi, Mariela Sanda Militaru

760–771
Molecular and immune characteristics of neuroendocrine bladder carcinoma — Implications for diagnosis, prognosis, and therapy: A review

Tianxiang Zhang, Xi Zhang, Lei Qian, Chunjiang Hu, Jianxing Li
Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker

Lucija Škara, Tonći Vodopić, Ivan Pezelj, Irena Abramovic, Borna Vrhovec, Alen Vrtarić, Nino Sincic, Davor Tomas, Stela Bulimbašić, Tomislav Kuliš, Monika Ulamec

176-186
Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy

Wenjie Yang, Lin Ma, Jie Dong, Mengchao Wei, Ruoyu Ji, Hualin Chen, Xiaoqiang Xue, Yingjie Li, Zhaoheng Jin, Weifeng Xu, Zhigang Ji

471–482
Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models

Yizeng Xu, Fang Lu, Meng Wang, Lingchen Wang, Chaoyang Ye, Shuohui Yang, Chen Wang

1319–1330
JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation

Zhong-qi Pang, Jian-she Wang, Jin-feng Wang, Ya-xuan Wang, Bo Ji, Yi-dan Xu, Jia-xin He, Lu Zhang, Li-qiu Zhang, Bei-chen Ding, Yang Liu, Ming-hua Ren

897-911

1-20 of 41 Next

Nephrology and Urology

All Items

Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study

Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity

Tribbles pseudokinase 3 promoted renal fibrosis by regulating the expression of DNA damage-inducible transcript 3 in diabetic nephropathy

Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy

Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration

Serum cytokine profiles in children with IgA vasculitis with nephritis

Risk of graft loss in kidney transplant recipients after aortic valve replacement

Risk factors for recurrent IgA nephropathy after renal transplantation: A meta-analysis

Prognostic impact of sleep-disordered breathing on mortality and cardiovascular events in renal dialysis: A meta-analysis

Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Predicting overactive bladder from inflammatory markers: A machine learning approach using NHANES 2005–2020

PD-L1 expression in testicular germ cell tumors undergoing spontaneous regression

Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

Naringenin – a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence

Molecular basis and therapeutic targets in prostate cancer: A comprehensive review

Molecular and immune characteristics of neuroendocrine bladder carcinoma — Implications for diagnosis, prognosis, and therapy: A review

Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker

Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy

Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models

JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation

impact_factor_6

Sidebar_menu